Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast effects on airway inflammation in allergic children
2006-003216-22Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of montelukast in asthma and allergic rhinitis (AR) (2 cohorts), sponsored by Policlinico Gemelli. Primary endpoint: Nitric oxide concentration in exhaled breath. Started Jul 2007; status: completed.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on 2006-003216-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003216-22.